CDE Detailed Report

Disease: Stroke
Sub-Domain: Drugs
CRF: Antithrombotics and Risk Factor Controlling Medications

Displaying 1 - 15 of 15
CDE ID CDE Name Variable Name Definition Short Description Additional Notes (Question Text) Permissible Values Description Data Type Disease Specific Instructions Disease Specific Reference Population Classification (e.g., Core) Version Number Version Date CRF Name (CRF Module / Guideline) Sub Domain Name Domain Name Size Input Restrictions Min Value Max Value Measurement Type External Id Loinc External Id Snomed External Id caDSR External Id CDISC
C14635 Extracranial venous thromboembolism prophylaxis type ExtraCranVenThromProphylTyp Type(s) of extracranial venous thromboembolism (VTE) prophylaxis used Type(s) of extracranial venous thromboembolism (VTE) prophylaxis used Type(s) of VTE prophylaxis used Low dose unfractionated heparin (LDUH);Low molecular weight heparin (LMWH);Intermittent pneumatic compression devices (IPC);Factor Xa Inhibitor;Warfarin;Venous foot pumps (VFP);Oral Factor Xa inhibitor;Other, specify "regular" heparin;enoxaparin, dalteparin, nadroparin, danaparoid, heparinoids, etc.;;;Warfarin;Venous foot pumps (VFP);; Alphanumeric

Choose all that apply.

CMS/ The Joint Commission: SCIP-VTE-1, SCIP-VTE-2; The Joint Commission Only: STK-1, VTE-1 Adult;Pediatric Supplemental 3.00 2013-06-21 00:00:00.0 Antithrombotics and Risk Factor Controlling Medications Drugs Treatment/Intervention Data

Multiple Pre-Defined Values Selected

C14636 Heparin venous thromboembolism (VTE) prophylaxis dose HeparinVenThrombembProphDose Dose of heparin used to treat the extracranial venous thromboembolism (VTE), including the units for dose Dose of heparin used to treat the extracranial venous thromboembolism (VTE), including the units for dose Provide dose Numeric Values

Indicate the numeric dose along with its unit of measurement.

No references available Adult;Pediatric Supplemental 3.00 2013-06-21 00:00:00.0 Antithrombotics and Risk Factor Controlling Medications Drugs Treatment/Intervention Data

Free-Form Entry

C14637 Stroke discharge medication category StrokDisMedCat Class(es) of medications the participant/ subject was prescribed at hospital discharge following stroke Class(es) of medications the participant/ subject was prescribed at hospital discharge following stroke Which class(es) of medications was the participant/subject prescribed at hospital discharge Anticoagulants;Antiplatelets;Antihypertensives;Anti-diabetic agents;Lipid lowering agents Anticoagulants;Antiplatelets;Antihypertensives;Anti-diabetic agents;Lipid lowering agents Alphanumeric

Choose all that apply

Supplemental - Highly Recommended based on study type, disease stage and disease type

No references available Adult;Pediatric Supplemental-Highly Recommended 3.00 2013-06-21 00:00:00.0 Antithrombotics and Risk Factor Controlling Medications Drugs Treatment/Intervention Data

Multiple Pre-Defined Values Selected

C14638 Antithrombotic therapy not prescribed reason AntithromTherNotPresRsn Reason(s) for not prescribing antithrombotic therapy (i.e., no anticoagulants or antiplatelets), documented by a physician, advance practice nurse or physician assistant. Reason(s) for not prescribing antithrombotic therapy (i.e., no anticoagulants or antiplatelets), documented by a physician, advance practice nurse or physician assistant. Reason(s) antithrombotic therapy was not prescribed at hospital discharge Allergy to or complication related to aspirin, ticlopidine, clopidogrel, dipyridamole, warfarin or heparins (history or current);Patient/Family refused;Risk for bleeding or discontinued due to bleeding;Serious side effect to medication;Terminal illness/Comfort measures only;Other, specify Allergy to or complication related to aspirin, ticlopidine, clopidogrel, dipyridamole, warfarin or heparins (history or current);Patient/Family refused;Risk for bleeding or discontinued due to bleeding;Serious side effect to medication;Terminal illness/Comfort measures only;Other, specify Alphanumeric

Choose all that apply. If reasons are not mentioned in the context of antithrombotics, do not make inferences (e.g., do not assume that antithrombotics are not being prescribed because of a bleeding disorder unless documentation explicitly states so).

Get With The Guidelines (GWTG) Stroke Patient Management Tool Coding Instructions (Updated on 11/4/2009); Paul Coverdell National Acute Stroke Registry Adult;Pediatric Supplemental 3.00 2013-06-21 00:00:00.0 Antithrombotics and Risk Factor Controlling Medications Drugs Treatment/Intervention Data

Multiple Pre-Defined Values Selected

C18984 Anticoagulant other text AnticoagOTH The free-text field related to 'Anticoagulant type' specifying other text. Type(s) of anticoagulants received The free-text field related to 'Anticoagulant type' specifying other text. Type(s) of anticoagulants received Other, specify Alphanumeric

Choose all that apply.

Supplemental - Highly Recommended based on study type, disease stage and disease type

Get With The Guidelines (GWTG) Stroke Patient Management Tool Coding Instructions (Updated on 11/4/2009); Paul Coverdell National Acute Stroke Registry Adult;Pediatric Supplemental-Highly Recommended 3.00 2013-06-21 00:00:00.0 Antithrombotics and Risk Factor Controlling Medications Drugs Treatment/Intervention Data 4000

Free-Form Entry

C14629 Anticoagulant in hospital indicator AnticoagHospInd Whether the participant/ subject received arterial dose anticoagulants during the acute hospital stay, not including venous prophylaxis dose Unfractionated heparin, LMW heparin, etc. Whether the participant/ subject received arterial dose anticoagulants during the acute hospital stay, not including venous prophylaxis dose Unfractionated heparin, LMW heparin, etc. Did the participant/subject receive arterial dose anticoagulants Yes;No;Unknown Yes;No;Unknown Alphanumeric

Choose one

Supplemental - Highly Recommended based on study type, disease stage and disease type

Get With The Guidelines (GWTG) Stroke Patient Management Tool Coding Instructions (Updated on 11/4/2009) Adult;Pediatric Supplemental-Highly Recommended 3.00 2013-06-21 00:00:00.0 Antithrombotics and Risk Factor Controlling Medications Drugs Treatment/Intervention Data

Single Pre-Defined Value Selected

C18985 Antiplatelet other text AntiplatOTH The free-text field related to 'Antiplatelet type' specifying other text. Type(s) of antiplatelets received The free-text field related to 'Antiplatelet type' specifying other text. Type(s) of antiplatelets received Other, specify Alphanumeric

Choose all that apply.

Supplemental - Highly Recommended based on study type, disease stage and disease type

Get With The Guidelines (GWTG) Stroke Patient Management Tool Coding Instructions (Updated on 11/4/2009); Paul Coverdell National Acute Stroke Registry Adult;Pediatric Supplemental-Highly Recommended 3.00 2013-06-21 00:00:00.0 Antithrombotics and Risk Factor Controlling Medications Drugs Treatment/Intervention Data 4000

Free-Form Entry

C14630 Anticoagulant type AnticoagTyp Type(s) of anticoagulants received Type(s) of anticoagulants received Type(s) of anticoagulants received Unfractionated heparin IV;Full dose LMW heparin (Enoxaparin , Others);Warfarin (Coumadin);Fondaparinux (Arixtra);Other, specify Unfractionated heparin IV;Full dose LMW heparin (Enoxaparin , Others);Warfarin (Coumadin);Fondaparinux (Arixtra);Other, specify Alphanumeric

Choose all that apply.

Supplemental - Highly Recommended based on study type, disease stage and disease type

Get With The Guidelines (GWTG) Stroke Patient Management Tool Coding Instructions (Updated on 11/4/2009); Paul Coverdell National Acute Stroke Registry Adult;Pediatric Supplemental-Highly Recommended 3.00 2013-06-21 00:00:00.0 Antithrombotics and Risk Factor Controlling Medications Drugs Treatment/Intervention Data

Multiple Pre-Defined Values Selected

C18986 Extracranial venous thromboembolism other text ExtraCranVenThromOTH The free-text field related to 'Extracranial venous thromboembolism type' specifying other text. Type(s) of extracranial venous thromboembolism (VTE) diagnosed with The free-text field related to 'Extracranial venous thromboembolism type' specifying other text. Type(s) of extracranial venous thromboembolism (VTE) diagnosed with Other, specify Alphanumeric

Choose all that apply.

No references available Adult;Pediatric Supplemental 3.00 2013-06-21 00:00:00.0 Antithrombotics and Risk Factor Controlling Medications Drugs Treatment/Intervention Data 4000

Free-Form Entry

C14631 Antiplatelet in hospital indicator AntiplatelHospInd Whether the participant/ subject received arterial dose antiplatelets during the acute hospital stay Whether the participant/ subject received arterial dose antiplatelets during the acute hospital stay Did the participant/subject receive arterial dose antiplatelets Yes;No;Unknown Yes;No;Unknown Alphanumeric

Choose one

Supplemental - Highly Recommended based on study type, disease stage and disease type

No references available Adult;Pediatric Supplemental-Highly Recommended 3.00 2013-06-21 00:00:00.0 Antithrombotics and Risk Factor Controlling Medications Drugs Treatment/Intervention Data

Single Pre-Defined Value Selected

C18987 Extracranial venous thromboembolism prophylaxis other text ExtraCranVenThromProphylOTH The free-text field related to 'Extracranial venous thromboembolism prophylaxis type' specifying other text. Type(s) of extracranial venous thromboembolism (VTE) prophylaxis used The free-text field related to 'Extracranial venous thromboembolism prophylaxis type' specifying other text. Type(s) of extracranial venous thromboembolism (VTE) prophylaxis used Type(s) of VTE prophylaxis used Alphanumeric

Choose all that apply.

CMS/ The Joint Commission: SCIP-VTE-1, SCIP-VTE-2; The Joint Commission Only: STK-1, VTE-1 Adult;Pediatric Supplemental 3.00 2013-06-21 00:00:00.0 Antithrombotics and Risk Factor Controlling Medications Drugs Treatment/Intervention Data 4000

Free-Form Entry

C14632 Antiplatelet type AntiplatTyp Type(s) of antiplatelets received Type(s) of antiplatelets received Type(s) of antiplatelets received Aspirin;Aspirin/Dipyridamole (in separate formulations or as Aggrenox);Clopidogrel (Plavix);Ticlopidine (Ticlid);Other, specify Aspirin;Aspirin/Dipyridamole (in separate formulations or as Aggrenox);Clopidogrel (Plavix);Ticlopidine (Ticlid);Other, specify Alphanumeric

Choose all that apply.

Supplemental - Highly Recommended based on study type, disease stage and disease type

Get With The Guidelines (GWTG) Stroke Patient Management Tool Coding Instructions (Updated on 11/4/2009); Paul Coverdell National Acute Stroke Registry Adult;Pediatric Supplemental-Highly Recommended 3.00 2013-06-21 00:00:00.0 Antithrombotics and Risk Factor Controlling Medications Drugs Treatment/Intervention Data

Multiple Pre-Defined Values Selected

C18988 Antithrombotic therapy not prescribed other text AntithromTherNotPresOTH The free-text field related to 'Antithrombotic therapy not prescribed reason' specifying other text. Reason(s) for not prescribing antithrombotic therapy (i.e., no anticoagulants or antiplatelets), documented by a physician, advance practice nurse or physician assistant. The free-text field related to 'Antithrombotic therapy not prescribed reason' specifying other text. Reason(s) for not prescribing antithrombotic therapy, documented by a physician, advance practice nurse or physician assistant. Other, specify Alphanumeric

Choose all that apply. If reasons are not mentioned in the context of antithrombotics, do not make inferences (e.g., do not assume that antithrombotics are not being prescribed because of a bleeding disorder unless documentation explicitly states so).

Get With The Guidelines (GWTG) Stroke Patient Management Tool Coding Instructions (Updated on 11/4/2009); Paul Coverdell National Acute Stroke Registry Adult;Pediatric Supplemental 3.00 2013-06-21 00:00:00.0 Antithrombotics and Risk Factor Controlling Medications Drugs Treatment/Intervention Data 4000

Free-Form Entry

C14633 Extracranial venous thromboembolism indicator ExtraVenThromInd Whether the participant/ subject was diagnosed with an extracranial venous thromboembolism (VTE) Whether the participant/ subject was diagnosed with an extracranial venous thromboembolism (VTE) Was the participant/subject diagnosed with VTE Yes;No;Unknown Yes;No;Unknown Alphanumeric

Choose one

No references available Adult;Pediatric Supplemental 3.00 2013-06-21 00:00:00.0 Antithrombotics and Risk Factor Controlling Medications Drugs Treatment/Intervention Data

Single Pre-Defined Value Selected

C14634 Extracranial venous thromboembolism type ExtraCranVenThromTyp Type(s) of extracranial venous thromboembolism (VTE) diagnosed with Type(s) of extracranial venous thromboembolism (VTE) diagnosed with Diagnosis with which type(s) Deep venous thrombosis (DVT);Pulmonary embolism;Other, specify Deep venous thrombosis (DVT);Pulmonary embolism;Other, specify Alphanumeric

Choose all that apply.

No references available Adult;Pediatric Supplemental 3.00 2013-06-21 00:00:00.0 Antithrombotics and Risk Factor Controlling Medications Drugs Treatment/Intervention Data

Multiple Pre-Defined Values Selected

CSV